The Infamous Erlotinib Study
Aug 04, 2022•14 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
An infamous study that led to a drug approval of limited benefit, but still made its way into an episode of Better Call Saul.
Erlotinib + gemcitabine vs. gemcitabine: https://doi.org/10.1200/jco.2006.07.9525
For the best experience, listen in Metacast app for iOS or Android